Medicine: Drug Business

There was a sharp fall in stockmarket prices last week (see p. 50). But it scarcely affected the securities of those eight great U. S. manufacturing and retail drug concerns who have listed their stocks with the New York Stock and Curb exchange.* This despite the fact that their business this spring has not been so good as usual due: 1) to the absence of an influenza epidemic last winter; 2) to the smaller purchasing power of drugstore customers affected by current unemployment and business depression. This second cause is a shock to...

Want the full story?

Subscribe Now

Subscribe
Subscribe

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!